Malarial Cytokine Responses Reduced by Age in Exposed Children
|
By LabMedica International staff writers Posted on 10 Jan 2018 |

Image: The MAGPIX CCD Imager, a compact multiplexing unit (Photo courtesy of Luminex).
Elevated levels of pro-inflammatory cytokines and chemokines in the peripheral blood during acute malaria infection contribute to the control of parasitemia, but are also responsible for much of the immunopathology seen during symptomatic disease.
Young children are at greatest risk for malaria-associated morbidity and mortality. The immune response of young children differs in fundamental ways from that of adults, and these differences likely contribute to the increased susceptibility of children to severe malaria and to their delayed development of immunity.
An international team of scientists working with those at University of California San Francisco (CA, USA) obtained blood samples from study cohort that was initiated in 2011 and is ongoing. This cohort consists of 100 households where malaria transmission in this region is holoendemic, with an annual entomological inoculation rate (EIR) of 310 infective bites per person year. In total, plasma samples from 48 children were analyzed: 25 from children 1 to 3 years old and 23 from children 7 to 10 years old.
Thick blood smears were stained with 2% Giemsa for 30 minutes. Thick smears were evaluated for the presence of parasitemia (asexual forms only) and gametocytes. The concentrations of 20 cytokines and chemokines were measured in plasma samples using Luminex technology. Fourteen cytokines and six chemokines were analyzed using a custom R&D Magnetic Luminex Screening Assay Human Premixed Multi-Analyte Kit and read on a Luminex MAGPIX CCD Imager. Human interferon gamma (IFNγ) OptEIA ELISA II Kits were used to quantify IFNγ levels in plasma.
The team found that younger children presenting with acute malaria exhibited much higher levels of tumor necrosis factor (TNF), interleukin-2 (IL2), and IL6, as well as increased T helper cells (Th1) associated chemokines interferon gamma-induced protein 10 (IP10), Monokine induced by gamma interferon (MIG), and monocyte chemoattractant protein-1 (MCP1), was compared to older children with acute malaria. Additionally, the regulatory cytokines IL10 and tumor necrosis factor receptor 1 (TNFRI) were dramatically elevated in younger children compared to older children during acute infection, indicating that regulatory as well as pro-inflammatory cytokine responses are dampened in later childhood.
The authors concluded that that despite age-related differences in immune responses, young children respond with a largely pro-inflammatory Th1-type cytokine and chemokine response, similar to naïve travelers; however, they also show increased levels of the regulatory cytokines IL10 and soluble TNFRI, which may limit their ability to develop robust immunity to subsequent malaria infections. The study was published on December 29, 2017, in the Malaria Journal.
Related Links:
University of California San Francisco
Young children are at greatest risk for malaria-associated morbidity and mortality. The immune response of young children differs in fundamental ways from that of adults, and these differences likely contribute to the increased susceptibility of children to severe malaria and to their delayed development of immunity.
An international team of scientists working with those at University of California San Francisco (CA, USA) obtained blood samples from study cohort that was initiated in 2011 and is ongoing. This cohort consists of 100 households where malaria transmission in this region is holoendemic, with an annual entomological inoculation rate (EIR) of 310 infective bites per person year. In total, plasma samples from 48 children were analyzed: 25 from children 1 to 3 years old and 23 from children 7 to 10 years old.
Thick blood smears were stained with 2% Giemsa for 30 minutes. Thick smears were evaluated for the presence of parasitemia (asexual forms only) and gametocytes. The concentrations of 20 cytokines and chemokines were measured in plasma samples using Luminex technology. Fourteen cytokines and six chemokines were analyzed using a custom R&D Magnetic Luminex Screening Assay Human Premixed Multi-Analyte Kit and read on a Luminex MAGPIX CCD Imager. Human interferon gamma (IFNγ) OptEIA ELISA II Kits were used to quantify IFNγ levels in plasma.
The team found that younger children presenting with acute malaria exhibited much higher levels of tumor necrosis factor (TNF), interleukin-2 (IL2), and IL6, as well as increased T helper cells (Th1) associated chemokines interferon gamma-induced protein 10 (IP10), Monokine induced by gamma interferon (MIG), and monocyte chemoattractant protein-1 (MCP1), was compared to older children with acute malaria. Additionally, the regulatory cytokines IL10 and tumor necrosis factor receptor 1 (TNFRI) were dramatically elevated in younger children compared to older children during acute infection, indicating that regulatory as well as pro-inflammatory cytokine responses are dampened in later childhood.
The authors concluded that that despite age-related differences in immune responses, young children respond with a largely pro-inflammatory Th1-type cytokine and chemokine response, similar to naïve travelers; however, they also show increased levels of the regulatory cytokines IL10 and soluble TNFRI, which may limit their ability to develop robust immunity to subsequent malaria infections. The study was published on December 29, 2017, in the Malaria Journal.
Related Links:
University of California San Francisco
Latest Microbiology News
- Rapid Gastrointestinal PCR Panels Deliver One-Hour Results
- H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention
- Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer
- Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella
- Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread
- Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori
- Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE
- New Protein Targets Support Diagnostics for Louse-Borne Relapsing Fever
- TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
- Automated Blood Culture System Speeds Detection of Bloodstream Infections
- New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
- Gut Microbiome Signatures Help Identify Risk of IBD Progression
- FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets
- New AMR Assay Supports Rapid Infection Control Screening in Hospitals
- Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo
- Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Channels
Clinical Chemistry
view channel
Alzheimer’s Biomarkers Identify Faster Cognitive Decline in Adults Over 80
Diagnosing the cause of cognitive decline in adults over 80 is challenging because multiple comorbidities can blur early clinical presentations. As a result, memory complaints are often attributed to normal... Read more
ADLM Issues Laboratory Guidance for Gender-Diverse Patient Care
Laboratory medicine increasingly intersects with gender-affirming care, where hormone therapy and rigid health record fields can complicate the interpretation of routine tests. Without appropriate clinical... Read moreMolecular Diagnostics
view channel
Blood Test Helps Guide Post-Surgical Treatment in Metastatic Colorectal Cancer
Colorectal cancer is the third most common malignancy worldwide and the second-leading cause of cancer death. The liver is the most frequent site of spread, and although surgery offers the best chance... Read more
Blood Test Using Circular RNA Biomarkers Predicts Alzheimer’s Progression
Alzheimer’s disease evaluation commonly relies on plasma phosphorylated tau 217, along with invasive cerebrospinal fluid (CSF) testing and expensive PET. Blood-based approaches that can stratify risk years... Read moreHematology
view channel
Blood Test Helps Predict Short-Term Mortality After Severe Heart Attack
ST-elevation myocardial infarction (STEMI) is a severe heart attack caused by complete blockage of a coronary artery. Early risk stratification at hospital admission is challenging but essential for guiding... Read more
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read moreMicrobiology
view channel
Rapid Gastrointestinal PCR Panels Deliver One-Hour Results
Acute infectious gastroenteritis remains a major cause of illness worldwide, especially in young children, older adults, and immunocompromised patients. Nonspecific symptoms such as diarrhea, vomiting,... Read more
H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention
Health systems increasingly rely on economic evidence to guide cancer prevention strategies. For gastric cancer, selecting screening approaches that can integrate with existing programs is a key policy question.... Read more
Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer
Colorectal cancer has been repeatedly linked to alterations in the gut microbiome, yet findings have often varied across small, heterogeneous studies. Reproducibility has been limited by differing sequencing... Read morePathology
view channel
EBV Status Helps Predict Survival in Primary CNS Lymphoma
Primary central nervous system lymphoma is a rare malignancy in which tumors arise in the brain and, less often, the spinal cord, eyes, or cerebrospinal fluid. Outcomes are especially variable when the... Read more
AI Pathology Tool Predicts Immunotherapy Response in Rare Cancers
Immunotherapy has transformed care for select malignancies, yet predicting which patients with rare cancers are most likely to benefit remains challenging. Clinicians often have only limited biomarkers... Read moreTechnology
view channel
New CE-Certified Software Advances Whole-Genome Cancer Testing
European hospitals are increasingly using comprehensive tumor genomics to guide therapy, but routine whole genome sequencing (WGS) requires validated, regulation-compliant workflows. A newly CE-certified... Read more
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read moreIndustry
view channel
Eurobio Scientific Completes Acquisition of CareDx Lab Products Division
Eurobio Scientific has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitute CareDx’s Lab Products division. The business will... Read more
Blood-Based CRISPR Test for Tuberculosis Gains Regulatory Approval in Colombia
Colombia remains a high-priority setting for tuberculosis, with a growing need for diagnostics that complement existing testing strategies and improve access to earlier diagnosis. Solutions that function... Read more








